You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
永勝醫療(01612.HK):呼吸濕化治療儀及無創呼吸機獲授FDA緊急使用授權
格隆匯 05-21 16:38

格隆匯5月21日丨永勝醫療(01612.HK)發佈公告,集團的InspiredTM O2FLO呼吸濕化治療儀(“O2FLO”)及配件以及和普樂TM ST730無創呼吸機(“ST730”)最近獲美國食品藥品監督管理局(“FDA”)授予緊急使用授權。

根據披露,O2FLO是非侵入式高流量給氧治療器械,向能自主呼吸的患者輸出經加熱和濕化的氣體。高流量給氧治療一直用於治療慢性或急性呼吸窘迫,例如肺炎、病毒性肺炎(例如新型冠狀病毒病)、慢性阻塞性肺病和哮喘的患者。高流量給氧治療是為提供呼吸支持而開發的新興療法,臨牀證實對合適的患者採用高流量給氧治療可以改善氧合作用,能減少患者的呼吸作功,是一種相比侵入性機械通氣更安全和更經濟的替代治療。高流量給氧治療現已用於重症監護病房、急症室和家居護理環境,為廣泛的患者提供治療。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account